Stockscreener 앱 받기
1.22
4.27%
0.05
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
Price to sales forward of Tiziana Life Sciences Ltd – NASDAQ:TLSA - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (DUS:0RP) - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (NASDAQ:TLSA) - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (FWB:0RP) - TradingView
TLSA Forecast — Price Target — Prediction for 2027 - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (TRADEGATE:0RP) - TradingView
Small cap wrap: Power Metallic Mines, Tiziana Life Sciences, Fox Tungsten, American Resources… - Proactive financial news
0RP Forecast — Price Target — Prediction for 2027 - TradingView
Could Intranasal Innovation Shape the Future of Multiple Sclerosis Care? - Kalkine Media
Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial - Yahoo! Finance Canada
Tiziana Life Sciences (TLSA) Advances Clinical Trial for Multiple Sclerosis Treatment - GuruFocus
Tiziana Life Sciences Doses Last Patient in Phase 2 Trial of Potential Multiple Sclerosis Treatment - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Tiziana (Nasdaq: TLSA) completes enrollment in Phase 2a INFORM-MS study - Stock Titan
Tiziana Life Sciences Ltd. - Via Ritzau
Tiziana Life Sciences Ltd (TLSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tiziana Life Sciences Ltd (TLSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tiziana Life Sciences Ltd (TLSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tiziana Life Sciences Ltd (TLSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Why Tiziana Life Sciences Is Back on the Small-Cap Radar? - Kalkine Media
Tiziana Life Sciences Ltd (TLSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tiziana Life Sciences Ltd (TLSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tiziana Life Sciences Ltd (TLSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tiziana Life Sciences Ltd (TLSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tiziana Life Sciences Ltd (TLSA) Institutional Confidence - TradingKey
Tiziana Life Sciences (TLSA) insider awarded 15,000 common shares - Stock Titan
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance - The Globe and Mail
Tiziana Life Sciences Ltd announced that it has received $0.01665 million in funding - marketscreener.com
Tiziana Life Sciences (TLSA) Executive Chairman Boosts Stake wit - GuruFocus
Tiziana Life Sciences (TLSA) Executive Chairman Boosts Shareholding - GuruFocus
Tiziana executive chairman increases stake - Proactive financial news
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - The Manila Times
Tiziana (NASDAQ: TLSA) chair lifts stake with 15,000-share purchase - Stock Titan
Founder now owns 34.89% of Tiziana Life Sciences after 15K-share buy - Stock Titan
Tiziana Life Sciences (TLSA) Retreats 2.6% as Shares Approach Key SupportGolden Cross - newsline.com
[6-K] Tiziana Life Sciences Ltd Current Report (Foreign Issuer) | TLSA SEC FilingForm 6-K - Stock Titan
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York - NTB Kommunikasjon
Tiziana Life Sciences to present clinical updates at Jefferies healthcare conference - Proactive financial news
Biotech Tiziana to brief investors on clinical updates at Jefferies event - Stock Titan
Tiziana Life Sciences (TLSA) Slips 2.65% as Stock Tests Key Support ZoneVolume Oscillator - The Legal Advocate
TLSATiziana Life Sciences Ltd Stock Price and Quote - Finviz
Tiziana Life Sciences (TLSA) COO discloses Form 3 share and option holdings - Stock Titan
Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI - Yahoo! Finance Canada
Tiziana Life Sciences completes enrollment in Phase 2a trial for multiple sclerosis drug foralumab - Pluang
Tiziana Life Sciences (TLSA) Completes Patient Enrollment in Cli - GuruFocus
Tiziana completes enrollment for Phase 2 trial in progressive MS study - Proactive financial news
Why Is TLSA Stock Rising Today? - Stocktwits
Tiziana Life Sciences completes enrollment in Phase 2a multiple sclerosis trial - Yahoo! Finance Canada
Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial - The Manila Times
Phase 2a MS trial fully enrolled at Tiziana Life Sciences (NASDAQ: TLSA) - Stock Titan
Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN
Tiziana Life Sciences (TLSA) Reports Positive Data on Foralumab for Multiple Sclerosis - GuruFocus
Updated Clinical Results for Tiziana Life Sciences (TLSA) Show P - GuruFocus
Tiziana Life Sciences price target boosted on foralumab update - Yahoo! Finance Canada
Market movers: Amer Sports, Tiziana Life Sciences, Ideal Power, NanoViricides... - Proactive financial news
Tiziana reports encouraging Expanded Access data for Foralumab in MS patients - Proactive financial news
Tiziana posts new data for multiple sclerosis drug (TLSA) - Seeking Alpha
1.60%
3.59%
자본화:
|
볼륨(24시간):